Cargando…
Long-term Outcomes of Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study from CSTAR Registry
OBJECTIVE: To study the long-term outcomes, in the context of both mortality and organ damage in patients with systemic lupus erythematosus (SLE) in the Chinese SLE Treatment and Research group (CSTAR) registry cohort. METHODS: Patients were enrolled from April 2009 to February 2010 and they were fo...
Autores principales: | Wang, Ziqian, Li, Mengtao, Ye, Zhizhong, Li, Caifeng, Li, Zhijun, Li, Xiangpei, Wu, Lijun, Liu, Shengyun, Zuo, Xiaoxia, Zhu, Ping, Wang, Zhengang, Ma, Li, Zhang, Miaojia, Hou, Zhiduo, Bi, Liqi, Wang, Yanhong, Zhao, Jiuliang, Wang, Qian, Tian, Xinping, Zeng, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524789/ https://www.ncbi.nlm.nih.gov/pubmed/36465068 http://dx.doi.org/10.2478/rir-2021-0025 |
Ejemplares similares
-
Chinese SLE Treatment and Research Group (CSTAR) Registry 2009–2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus
por: Li, Mengtao, et al.
Publicado: (2021) -
Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII
por: Gui, Yinli, et al.
Publicado: (2022) -
Annual Direct Cost and Cost-Drivers of Systemic Lupus Erythematosus: A Multi-Center Cross-Sectional Study from CSTAR Registry
por: Wang, Haiyan, et al.
Publicado: (2023) -
Risk assessment in systemic lupus erythematosus-associated pulmonary
arterial hypertension: CSTAR-PAH cohort study
por: Wang, Qian, et al.
Publicado: (2022) -
Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study
por: Jiang, Nan, et al.
Publicado: (2022)